Currently Viewing:
Newsroom
Currently Reading
What We're Reading: Centivo Launches New Plan; Dead Bacteria Provide IBS Relief; Hospitals Using CGM in Patients With COVID-19
April 09, 2020 – AJMC Staff
New Machine Learning Model Predicts Who Will Develop Diabetes
April 07, 2020 – Gianna Melillo
Lost Time From Work Due to COVID-19 Could Cost Employers Billions, Study Finds
April 06, 2020 – Matthew Gavidia
This Week in Managed Care: April 3, 2020
April 03, 2020
Women With GDM, Vitamin D Deficiency May Have Higher Risk of Postpartum Glucose Intolerance
April 02, 2020 – Gianna Melillo
Small Businesses, Workers Struggling to Afford Economic Lockdown
April 02, 2020 – Matthew Gavidia
Managing COVID-19 via Telehealth: How Innovaccer's Self-assessment Tool Assists Patients in Determining Severity Risk
March 26, 2020 – Matthew Gavidia
Study Finds Diabetes Pay-for-Performance Program Reduces All-Cause Mortality
March 23, 2020 – Alison Rodriguez
AJMC® in the Press, March 20, 2020
March 20, 2020 – AJMC Staff

What We're Reading: Centivo Launches New Plan; Dead Bacteria Provide IBS Relief; Hospitals Using CGM in Patients With COVID-19

AJMC Staff
Centivo has launched a new health plan solution, aimed at lowering costs for employees; trial results show dead bacteria may be effective in treating IBS; continuous glucose monitoring systems are now being used in hospitalized patients with diabetes and coronavirus disease 2019 (COVID-19). 

Centivo Announces Self-Funded Health Plan Solution

Today, Centivo launched a self-funded health plan solution, available to employers in New York City and Orlando and Jacksonville Florida. The new plan options for employees include low-cost, primary care–based models. Advanced analytics that create cost-effective networks with health systems and independent practice partners will help employees navigate the health system and lead patients to the right specialists. Centivo will partner with Mount Sinai Health System and ProHealth in New York and with Orlando Health in Florida. The goal is to bring down healthcare costs by incentivizing providers to focus on high-value care.



Trial Results Found Probiotic Treatment May Relieve IBS

Results from a clinical trial published in The Lancet show that probiotics containing dead bacteria may be effective in relieving irritable bowel syndrome (IBS). In the trial, 221 participants received dead Bifidobacteria, which has been shown to be effective in live forms yet can cause severe adverse effects. Around one-third of patients who received the treatment reported reduced abdominal pain compared with only 19% who reported the same outcome in the placebo group; however, over 90% of participants in the treatment group also reported that the adverse effects were tolerable.



Diabetes Technology Used in Patients With COVID-19

Continuous glucose monitoring systems produced by Abbott and Dexcom are now being used in hospitalized patients with diabetes and coronavirus disease 2019 (COVID-19) to provide remote monitoring of glucose levels. The companies hope the technology will help limit health workers’ exposure to patients with COVID-19, while providing optimal care for patients with diabetes. The CDC notes diabetes is one of the underlying health conditions that, when poorly managed, can lead to more severe outcomes in patients with COVID-19. Currently, more that 50% of individuals with diabetes who also have COVID-19 are hospitalized, the CDC reports.

Related Articles

Total Costs of IBS: Employer and Managed Care Perspective
Plecanatide Shows Promise in Trials for Treating IBS With Constipation
ADA Issues Time-in-Range Targets for CGM Use
Abbott, Omada Health to Combine Digital Coaching With CGM for Those With Type 2 Diabetes
Lost Time From Work Due to COVID-19 Could Cost Employers Billions, Study Finds
 
Copyright AJMC 2006-2020 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up